Aptima HR-HPV Testing of Cytology Specimens Is an Effective Supplement for p16 Staining to Improve Diagnostic Accuracy for HPV-Related Oropharyngeal Squamous Cell Carcinoma

被引:2
作者
Yang, Xin [1 ]
Hu, Chunfang [1 ]
Zhao, Huan [1 ]
Zhang, Zhihui [1 ]
Zhao, Linlin [1 ]
Yu, Jing [2 ]
Ni, Xiaoguang [3 ]
Guo, Huiqin [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Dept Pathol, Natl Canc Ctr,Canc Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Hebei Canc Hosp, Natl Canc Ctr, Dept Pathol,Natl Clin Res Ctr Canc, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Endoscopy,Natl Clin Res Ctr Canc, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Oropharyngeal squamous cell carcinoma; Human papilloma virus; Aptima; p16; Brush cytology; E6/E7; MESSENGER-RNA; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; ORAL-CAVITY; HEAD; RISK; SURVIVAL;
D O I
10.1159/000527951
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Introduction: Regarding a small proportion of oropharyngeal squamous cell carcinoma (OPSCC) patients who tested p16-positive but human papillomavirus (HPV)-negative, we attempted to perform HPV testing to improve the accuracy of HPV detection in OPSCC patients. Methods: We simultaneously performed Aptima HPV testing of cytological specimens and p16 immunohistochemistry (IHC) staining of histologic biopsies from the same cohort of patients with head and neck SCC (HNSCC). The cytological specimens included fine-needle aspiration specimens from patients with enlarged nodes and endoscopic brushing specimens from the primary lesions of patients without enlarged nodes. Cases with discordant results for p16 IHC staining and Aptima HPV testing were reexamined by a third method, RNAscope testing. Results: Sixty patients with HNSCC (39 OPSCC and 21 non-OPSCC) were recruited for examination of HPV status. Among these patients, 28 were p16+/HPV+, 29 were p16-/HPV-, 2 were p16+/HPV-, and 1 was p16-/HPV+. The overall concordance rate between Aptima HPV testing and p16 IHC was 95.0%. Three cases with discordant results for these two methods were reexamined by RNAscope testing, and all were confirmed to be HPV negative. The prevalence of HPV in OPSCC and non-OPSCC patients was 61.5% (24/39) and 19.0% (4/21), respectively. The sensitivity and negative predictive values of Aptima HPV testing and p16 IHC were consistent at 100%, while the specificity and positive predictive values were 96.9% and 96.6% versus 93.8% and 93.3%, respectively. Additionally, 30 OPSCCs were simultaneously examined and diagnosed by both brush cytology and biopsy pathology; six of these SCCs were underdiagnosed by histopathology but accurately diagnosed by supplemental brush cytology. Conclusion: Aptima HPV testing of cytology specimens can be used as an adjuvant examination to identify false-positive OPSCC patients after p16 IHC of biopsies, while brush cytology may be a supplemental method for the histologic diagnosis of malignant oropharyngeal tumors.
引用
收藏
页码:321 / 331
页数:11
相关论文
共 47 条
  • [21] Oropharyngeal Squamous Cell Carcinoma With Discordant p16 and HPV mRNA Results Incidence and Characterization in a Large, Contemporary United States Cohort
    Shinn, Justin R.
    Davis, Seth J.
    Lang-Kuhs, Krystle A.
    Rohde, Sarah
    Wang, Xiaowei
    Liu, Ping
    Dupont, William D.
    Plummer, Dale, Jr.
    Thorstad, Wade L.
    Chernock, Rebecca D.
    Mehrad, Mitra
    Lewis, James S., Jr.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (07) : 951 - 961
  • [22] Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status
    Benzerdjeb, Nazim
    Tantot, Juliet
    Blanchet, Christophe
    Philouze, Pierre
    Mekki, Yahia
    Lopez, Jonathan
    Devouassoux-Shisheboran, Mojgan
    HISTOPATHOLOGY, 2021, 79 (03) : 381 - 390
  • [23] A Case of HPV-Associated Oropharyngeal Squamous Cell Carcinoma with Block-Like, Partial Loss of p16 Expression
    Rasmussen, S. A.
    Lewis, J. S., Jr.
    Mirabello, L.
    Bass, S.
    Yeager, M.
    Corsten, M. J.
    Bullock, M. J.
    HEAD & NECK PATHOLOGY, 2022, 16 (04) : 1251 - 1256
  • [24] Expression of CK7, CK19 and p16 in HPV-mediated oropharyngeal squamous cell carcinoma
    Yan, Qizhang
    Chen, Pengning
    Chen, Xinyu
    Chen, Guanxi
    Luo, Lin
    Ruan, Ping
    Yu, Dahai
    Zeng, Xiaojuan
    Zhou, Mengyu
    PEERJ, 2024, 12
  • [25] p16 overexpression identifies oncogenic high-risk HPV infection in non-oropharyngeal squamous cell carcinoma of the head and neck
    Becker, Anne-Sophie
    Merkel, Jenny
    Bozkurt, Inci
    Strueder, Daniel Fabian
    Maletzki, Claudia
    Huehns, Maja
    Zimpfer, Annette Helene
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (10): : 2569 - 2581
  • [26] Equivocal p16 Immunostaining in Squamous Cell Carcinoma of the Head and Neck: Staining Patterns are Suggestive of HPV Status
    Zhongchuan Will Chen
    Ilan Weinreb
    Suzanne Kamel-Reid
    Bayardo Perez-Ordoñez
    Head and Neck Pathology, 2012, 6 (4) : 422 - 429
  • [27] Equivocal p16 Immunostaining in Squamous Cell Carcinoma of the Head and Neck: Staining Patterns are Suggestive of HPV Status
    Chen, Zhongchuan Will
    Weinreb, Ilan
    Kamel-Reid, Suzanne
    Perez-Ordonez, Bayardo
    HEAD & NECK PATHOLOGY, 2012, 6 (04): : 422 - 429
  • [28] HPV-Associated Squamous Cell Carcinoma of the Eyelid: Diagnostic Utility of p16 Immunohistochemistry and mRNA In Situ Hybridization
    Kakkar, Aanchal
    Srivastava, Kirti
    Deepa, S.
    Kashyap, Seema
    Sen, Seema
    Bhoriwal, Sandeep
    Kaur, Kavneet
    Deo, Suryanarayan V. S.
    HEAD & NECK PATHOLOGY, 2023, 17 (04) : 889 - 898
  • [29] Truth or myth: Definitive chemoradiotherapy doesn't work for HPV/p16 negative oropharyngeal squamous cell carcinoma?
    Chera, Bhisham
    Wang, Kyle
    Monroe, Alan
    Galloway, Tom
    Amdur, Robert
    Hayes, D. Neil
    Zevallos, Jose
    Mendenhall, William M.
    ORAL ONCOLOGY, 2017, 65 : 125 - 126
  • [30] Metastatic HPV-Associated Oropharyngeal Versus Primary Pulmonary Squamous Cell Carcinoma: is p16 Immunostain Useful?
    Jefree J. Schulte
    Jamie Steinmetz
    Larissa V. Furtado
    Aliya N. Husain
    Mark W. Lingen
    Nicole A. Cipriani
    Head and Neck Pathology, 2020, 14 : 966 - 973